2024 Program Announcements (PAs) | |
PA No. and Title | Status - Expiration |
---|---|
PAR24-122 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | ACTIVE - NOV 06, 2024 |
PAR24-117 The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional) | ACTIVE - MAR 13, 2027 |
PAR24-085 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | ACTIVE - JAN 08, 2027 |
PAR24-072 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | ACTIVE - JAN 08, 2027 |
PAR24-047 Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) | ACTIVE - OCT 14, 2026 |
PAR24-039 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) | ACTIVE - NOV 18, 2026 |
2020 Program Announcements (PAs) | |
PA No. and Title | Status - Expiration |
---|---|
PAR20-305 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) | EXPIRED - JAN 08, 2024 |